Literature DB >> 8837107

Cerebral gliosarcoma: prognostic factors.

L Cervoni1, P Celli.   

Abstract

The authors report their results in a retrospective study of 6 cases of gliosarcoma. In 3 cases gliosarcoma presented features similar to those of glioblastoma, both at CT scan and macroscopically; in the other 3 cases they resembled meningioma. Average survival varied considerably and was correlatable to the CT features of the lesion (14 months for glioblastoma, 7 for meningioma). It seems likely that patients who have gliosarcoma with CT features suggestive of meningioma may have prolonged survival.

Entities:  

Mesh:

Year:  1996        PMID: 8837107     DOI: 10.1007/bf00418077

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  10 in total

1.  The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation.

Authors:  I FEIGIN; L B ALLEN; L LIPKIN; S W GROSS
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

2.  Congenital gliosarcoma; so-called sarcoglioma.

Authors:  N Ono; M Nakamura; H K Inoue; M Tamura; M Murata
Journal:  Childs Nerv Syst       Date:  1990-11       Impact factor: 1.475

3.  [Metastasizing gliosarcoma].

Authors:  E Fliedner; W Entzian
Journal:  Acta Neurochir (Wien)       Date:  1972       Impact factor: 2.216

4.  Ultrastructure of a composite glioma-sarcoma of the brain.

Authors:  C E Peña; R Felter
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

5.  Clinical and pathological study of 24 cases of gliosarcoma.

Authors:  R A Morantz; I Feigin; J Ransohoff
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

6.  Angiographic features of gliosarcoma.

Authors:  C R Jack; D T Bhansali; J L Chason; R S Boulos; B A Mehta; S C Patel; W P Sanders
Journal:  AJNR Am J Neuroradiol       Date:  1987 Jan-Feb       Impact factor: 3.825

7.  Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

Authors:  F Slowik; K Jellinger; L Gaszó; J Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Mixed glioblastoma multiforme and sarcoma. A clinicopathologic study of 26 radiation therapy oncology group cases.

Authors:  J M Meis; K L Martz; J S Nelson
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

9.  Computed tomography of gliosarcoma.

Authors:  Y Y Lee; M Castillo; C Nauert; R P Moser
Journal:  AJNR Am J Neuroradiol       Date:  1985 Jul-Aug       Impact factor: 3.825

10.  Cerebral gliosarcomas: correlation of computed tomographic findings, surgical aspect, pathological features, and prognosis.

Authors:  F Maiuri; L Stella; D Benvenuti; A Giamundo; G Pettinato
Journal:  Neurosurgery       Date:  1990-02       Impact factor: 4.654

  10 in total
  5 in total

1.  Detailed magnetic resonance imaging features of a case series of primary gliosarcoma.

Authors:  Luísa Sampaio; Paulo Linhares; José Fonseca
Journal:  Neuroradiol J       Date:  2017-06-23

2.  Gliosarcomas: analysis of 11 cases do two subtypes exist?

Authors:  Maurizio Salvati; Emanuela Caroli; Antonino Raco; Felice Giangaspero; Roberto Delfini; Luigi Ferrante
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

3.  Gliosarcoma: a study of four cases.

Authors:  Yildiz Güney; Ayse Hiçsönmez; Sercan Yilmaz; Yasemin Güzle Adas; Meltem Nalca Andrieu
Journal:  Rare Tumors       Date:  2010-06-30

4.  Cerebral gliosarcoma: Analysis of 16 patients and review of literature.

Authors:  Gajendra Singh; Kuntal K Das; Pradeep Sharma; B Guruprasad; Sushila Jaiswal; Anant Mehrotra; Arun K Srivastava; Rabi N Sahu; Awadhesh K Jaiswal; Sanjay Behari
Journal:  Asian J Neurosurg       Date:  2015 Jul-Sep

Review 5.  Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.

Authors:  Seunggu J Han; Isaac Yang; Tarik Tihan; Michael D Prados; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-07-18       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.